Morning or afternoon? new study tests best time for lung cancer therapy
NCT ID NCT05549037
First seen Jun 12, 2026 · Last updated Jun 12, 2026
Summary
This study looked at whether giving a combination of immunotherapy and chemotherapy at a specific time of day helps people with advanced non-small cell lung cancer live longer without their disease getting worse. 210 adults who had not received prior treatment were randomly assigned to morning or afternoon infusions. The goal was to see if timing affects how long the cancer is controlled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hunan Cancer Hospital
Changsha, Hunan, 410013, China
Conditions
Explore the condition pages connected to this study.